Citius Pharmaceuticals (CTXR) Interest & Investment Income (2014 - 2026)
Citius Pharmaceuticals' Interest & Investment Income was $116,691 in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 465.4% from $20,637 a year earlier and up 117.8% from the prior quarter.
Citius Pharmaceuticals (CTXR) Interest & Investment Income (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Citius Pharmaceuticals' Interest & Investment Income was $268,795 through Jun 30, 2026, up 54.5% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $110,081, down 85.5% from FY2024.
- Interest & Investment Income shows a five-year compound annual growth rate of 10.1% (FY2020 to FY2025).
- In earlier fiscal years, Interest & Investment Income was $758,000 in FY2024 (-35.7%), $1.18 million in FY2023 (+369.1%), $251,399 in FY2022 (-4.0%) and $261,825 in FY2021 (+284.7%).
- The fiscal Q3 2026 figure marks the highest quarterly Interest & Investment Income since fiscal Q4 2024.
- Compared with a year earlier, Interest & Investment Income has increased for three straight quarters, with growth averaging 59.1% over the last eight quarters.
- The best year-over-year quarter for Interest & Investment Income over five years was fiscal Q2 2023 (growth of 925.6%); the worst was fiscal Q2 2025 (a decline of 92.6%).
- Per Business Quant data, CTXR's Interest & Investment Income in the three fiscal quarters before Q3 2026 was $53,584 (Q2 2026), $45,097 (Q1 2026) and $53,423 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Citius Pharmaceuticals | 13.45 Mn | -10.82 Mn | 1.00 Mn | 116,691.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 116,691.00 |
| Mar 31, 2026 | 53,584.00 |
| Dec 31, 2025 | 45,097.00 |
| Jun 30, 2025 | 20,637.00 |
| Mar 31, 2025 | 13,413.00 |
| Dec 31, 2024 | 22,608.00 |
| Jun 30, 2024 | 204,843.00 |
| Mar 31, 2024 | 182,205.00 |
| Dec 31, 2023 | 253,638.00 |
| Sep 30, 2023 | 324,813.00 |
| Jun 30, 2023 | 336,780.00 |
| Mar 31, 2023 | 303,275.00 |
| Dec 31, 2022 | 214,549.00 |
| Sep 30, 2022 | 134,826.00 |
| Jun 30, 2022 | 53,020.00 |
| Mar 31, 2022 | 29,571.00 |
| Dec 31, 2021 | 33,982.00 |
| Sep 30, 2021 | 75,601.00 |
| Jun 30, 2021 | 103,413.00 |
| Mar 31, 2021 | 69,327.00 |
Citius Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();